Bazar L S, Collier G B, Vanek P G, Siles B A, Kow Y W, Doetsch P W, Cunningham R P, Chirikjian J G
Georgetown University, Department of Biochemistry, and Molecular Biology, Washington DC, USA.
Electrophoresis. 1999 Jun;20(6):1141-8. doi: 10.1002/(SICI)1522-2683(19990101)20:6<1141::AID-ELPS1141>3.0.CO;2-7.
We introduce a novel experimental strategy for DNA mutation detection named the Mismatch Identification DNA Analysis System (MIDAS) [1, 2], which has an associated isothermal probe amplification step to increase target DNA detection sensitivity to attomole levels. MIDAS exploits DNA glycosylases to remove the sugar moiety on one strand (the probe strand) at a DNA base pair mismatch. The resulting apyrimidinic/ apurinic (AP) site is cleaved by AP endonucleases/lyases either associated with the DNA glycosylase or externally added to the reaction mixture. MIDAS utilizes 32p- or FITC-labeled oligonucleotides as mutation probes. Generally between 20-50 nucleotides in length, the probe hybridizes to the target sequence at the reaction temperature. Mismatch repair enzymes (MREs) then cut the probe at the point of mismatch. Once the probe is cleaved, the fragments become thermally unstable and fall off the target, thereby allowing another full-length probe to hybridize. This oscillating process amplifies the signal (cleaved probe). Cleavage products can be detected by electrophoretic separation followed by autoradiography, or by laser-induced fluorescence-capillary electrophoresis (LIF-CE) of fluorophore-labeled probes in two minutes using a novel CE matrix. In the present experiments, we employed the mesophilic Escherichia coli enzyme deoxyinosine 3'-endonuclease (Endo V), and a novel thermostable T/G DNA glycosylase, TDG mismatch repair enzyme (TDG-MRE). MIDAS differentiated between a clinical sample BRCA 1 wild-type sequence and a BRCA1 185delAG mutation without the need for polymerase chain reaction (PCR). The combination of MIDAS with LIF-CE should make detection of known point mutations, deletions, and insertions a rapid and cost-effective technique well suited for automation.
我们介绍了一种用于DNA突变检测的新型实验策略,称为错配识别DNA分析系统(MIDAS)[1,2],该系统具有相关的等温探针扩增步骤,可将目标DNA检测灵敏度提高到阿托摩尔水平。MIDAS利用DNA糖基化酶去除DNA碱基对错配处一条链(探针链)上的糖部分。产生的无嘧啶/无嘌呤(AP)位点被与DNA糖基化酶相关联的AP内切核酸酶/裂解酶或外部添加到反应混合物中的酶切割。MIDAS利用32P或FITC标记的寡核苷酸作为突变探针。探针长度一般在20 - 50个核苷酸之间,在反应温度下与目标序列杂交。错配修复酶(MREs)然后在错配点切割探针。一旦探针被切割,片段就会变得热不稳定并从目标上脱落,从而允许另一个全长探针杂交。这个振荡过程放大了信号(切割后的探针)。切割产物可以通过电泳分离后进行放射自显影检测,或者使用新型CE基质在两分钟内通过荧光团标记探针的激光诱导荧光毛细管电泳(LIF-CE)检测。在本实验中,我们使用了嗜温大肠杆菌酶脱氧肌苷3'-内切核酸酶(Endo V)和一种新型的热稳定T/G DNA糖基化酶、TDG错配修复酶(TDG-MRE)。MIDAS无需聚合酶链反应(PCR)就能区分临床样本BRCA 1野生型序列和BRCA1 185delAG突变。MIDAS与LIF-CE的结合应使已知点突变、缺失和插入的检测成为一种快速且经济高效的技术,非常适合自动化。